SanaRx Biotherapeutics, Inc — Form D

SanaRx Biotherapeutics, Inc of MEDFORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-04. The offering totals $1.2M, of which $355K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-10-04
• Form: D
• Accession: 0001788176-19-000001
• Industry: Biotechnology
• Exemptions: 04, 06b, 4a5
• Total offering: $1.2M
• Amount sold: $355K
• Remaining: $845K
• Investors: 8
• Date of first sale: 2019-09-23
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-350382

Issuer

• Name: SanaRx Biotherapeutics, Inc
• CIK: 0001788176
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 177 ARLINGTON STREET, MEDFORD, MA, 02155
• Phone: 617-412-6117

Officers, directors & promoters (10)

More

• CIK 1788176 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search